Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Accounts Payables (2020 - 2025)

Bio Essence (BIOE) has 6 years of Accounts Payables data on record, last reported at $10608.0 in Q3 2025.

  • For Q3 2025, Accounts Payables fell 66.96% year-over-year to $10608.0; the TTM value through Sep 2025 reached $10608.0, down 66.96%, while the annual FY2024 figure was $17738.0, 42.44% up from the prior year.
  • Accounts Payables reached $10608.0 in Q3 2025 per BIOE's latest filing, down from $337325.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $344419.0 in Q1 2025 and bottomed at $10608.0 in Q3 2025.
  • Average Accounts Payables over 5 years is $108051.6, with a median of $56534.0 recorded in 2023.
  • The widest YoY moves for Accounts Payables: up 13880.11% in 2021, down 88.28% in 2021.
  • A 5-year view of Accounts Payables shows it stood at $41841.0 in 2021, then plummeted by 44.96% to $23029.0 in 2022, then plummeted by 45.92% to $12453.0 in 2023, then surged by 42.44% to $17738.0 in 2024, then tumbled by 40.2% to $10608.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $10608.0 in Q3 2025, $337325.0 in Q2 2025, and $344419.0 in Q1 2025.